Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that an inherited nail condition often improves on its own, and spironolactone effectively treats acne in women.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Hirsutism requires identifying the cause to choose the right treatment, which may include medications like oral contraceptives or dexamethasone.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

A woman had a rare liver tumor causing male-like physical changes, highlighting the need for thorough checks when such symptoms appear.

Oral contraceptives help mild hirsutism, while flutamide and spironolactone help severe cases.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Antiandrogens help manage PCOS symptoms but need careful monitoring.

Use benzoyl peroxide, retinoids, antibiotics, and isotretinoin for acne, and combine treatments for better results.

AGA might indicate higher risk for severe COVID-19.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Hormonal treatments can effectively improve hidradenitis suppurativa symptoms.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Spironolactone may help reduce hair loss in androgenic alopecia.

The photographic method accurately measures hair growth and both treatments effectively reduced hair growth in hirsute women.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

Minoxidil is the only drug proven to improve female hair loss, and dextroamphetamine sulfate may be a new treatment for certain types of hair loss.